Clinical Assessment of Neuromuscular Transmission
The concept of neuromuscular transmission as a separate physiological entity was introduced by Claude Bernard in 1851 when he demonstrated by means of curare that the junction between nerve endings and muscle fibres possessed unique properties. The logic and simplicity of Bernard’s experiments have not been surpassed by more modern methods and they still offer a convenient and relatively inexpensive means of screening new drugs with a possible action at the neuromuscular junction. Bernard’s studies with curare focused attention on its peripheral actions and its therapeutic possibilities were soon recognised. By 1858 the drug had already been used in the management of tetanus and shortly thereafter albeit with less justification it had been employed in the treatment of a variety of diseases including chorea, epilepsy and hydrophobia.
KeywordsUlnar Nerve Neuromuscular Blockade Neuromuscular Block Neuromuscular Transmission Neuromuscular Blocking Agent
Unable to display preview. Download preview PDF.
- BERNARD, C. (1851). Action de Curare et de la Nicotine sur le systeme Nerveux et sur le systeme Musculaire. Compt. rend. Soc. Biol., 2, 195.Google Scholar
- BRISCOE, G. (1936). Shift in optimum rate of stimulation due to prostigmine. J. Physiol. (Lond.), 86, 48P.Google Scholar
- BRISCOE, G. (1937). Optimum stimulation rates for red and white skeletal mammalian muscles, and shift in rates produced by the eserine group. J. Physiol. (Lond.), 90, 10P.Google Scholar
- DESMEDT, J.E. (1962). Donnees recentes sur la pathogenie de la myasthenie grave. Bull, de l’Academie Royale de Medicine de Belgique, 7, 213–267.Google Scholar
- MACLAGAN, J. (1976). Competitive neuromuscular blocking drugs. In Neuromuscular Junction, ed Zaimis, E., pp 462–467 Berlin: Springer-Verlag.Google Scholar
- PRESTON, J.B. & VAN MAANAN, E.F. (1953). Effects of frequency of stimulation on the paralysing dose of neuromuscular blocking agents. J. Pharmac. exp. Ther., 107, 165–171.Google Scholar
- ROBERTS, D.V. & WILSON, A. (1969). Physiology of neuromuscular transmission. In Electromyography in diagnosis and treatment of myasthenia gravis, ed Green, R., pp 14—19. London: William Heinemann.Google Scholar
- WISLICKI, L. (1958). Effects of rate of stimulation and of fatigue on the response of neuromuscular blocking agents. Br. J. Pharmac., 13, 138–143.Google Scholar